Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 698.11 million compared to CNY 496.21 million a year ago. Net income was CNY 118.61 million compared to CNY 84.85 million a year ago. Basic earnings per share from continuing operations was CNY 0.11 compared to CNY 0.09 a year ago. Diluted earnings per share from continuing operations was CNY 0.11.